Europe Lyophilized Injectable Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Lyophilized Injectable Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Lyophilized Injectable Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Lyophilized Injectable Market Regional Analysis

6.2 Europe Lyophilized Injectable Market Revenue 2020-2028 (US$ Million)

6.3 Europe Lyophilized Injectable Market Forecast Analysis

7. Europe Lyophilized Injectable Market Analysis – by Type of Packaging

7.1 Single-Use Vials

7.1.1 Overview
7.1.2 Single-Use Vials: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Point-of-Care Reconstitution

7.2.1 Overview
7.2.2 Point-of-Care Reconstitution: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Specialty Packaging

7.3.1 Overview
7.3.2 Specialty Packaging: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Lyophilized Injectable Market Analysis – by Type of Delivery

8.1 Prefilled Diluent Syringes

8.1.1 Overview
8.1.2 Prefilled Diluent Syringes: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Single-Step Devices

8.2.1 Overview
8.2.2 Single-Step Devices: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Proprietary Reconstitution Devices

8.3.1 Overview
8.3.2 Proprietary Reconstitution Devices: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Multi-Step Devices

8.4.1 Overview
8.4.2 Multi-Step Devices: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Lyophilized Injectable Market Analysis – by Indication

9.1 Metabolic and Oncology Conditions

9.1.1 Overview
9.1.2 Metabolic and Oncology Conditions: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Infectious Diseases

9.2.1 Overview
9.2.2 Infectious Diseases: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Autoimmune Diseases

9.3.1 Overview
9.3.2 Autoimmune Diseases: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Lyophilized Injectable Market Analysis – by End User

10.1 Hospitals

10.1.1 Overview
10.1.2 Hospitals: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Ambulatory Surgical Centers

10.2.1 Overview
10.2.2 Ambulatory Surgical Centers: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Specialty Clinics

10.3.1 Overview
10.3.2 Specialty Clinics: Europe Lyophilized Injectable Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Lyophilized Injectable Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Lyophilized Injectable Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Lyophilized Injectable Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.1.2 UK: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.1.3 UK: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.1.4 UK: Europe Lyophilized Injectable Market Breakdown, by End User

11.2.1.2 Germany: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.2.2 Germany: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.2.3 Germany: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.2.4 Germany: Europe Lyophilized Injectable Market Breakdown, by End User

11.2.1.3 France: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.3.2 France: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.3.3 France: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.3.4 France: Europe Lyophilized Injectable Market Breakdown, by End User

11.2.1.4 Russia: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.4.2 Russia: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.4.3 Russia: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.4.4 Russia: Europe Lyophilized Injectable Market Breakdown, by End User

11.2.1.5 Italy: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.5.2 Italy: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.5.3 Italy: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.5.4 Italy: Europe Lyophilized Injectable Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Lyophilized Injectable Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Lyophilized Injectable Market Breakdown, by Type of Packaging
11.2.1.6.2 Rest of Europe: Europe Lyophilized Injectable Market Breakdown, by Type of Delivery
11.2.1.6.3 Rest of Europe: Europe Lyophilized Injectable Market Breakdown, by Indication
11.2.1.6.4 Rest of Europe: Europe Lyophilized Injectable Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Aristopharma Ltd.

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Baxter

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 CordenPharma International

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Credence MedSystems, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Curia Global, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Jubilant HollisterStier (Jubilant Pharma Limited)

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Nipro

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Recipharm AB

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 S.G. Biopharm Pvt. Ltd.

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Vetter Pharma

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Lyophilized Injectable Market